Svb Wealth LLC Biogen Inc. Transaction History

Svb Wealth LLC

$117 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$190.52 - $236.72 $75,636 - $93,977	397 Added 34.37%	1,552 $359,000
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $4,028 - $5,086	-19 Reduced 1.62%	1,155 $249,000
Q4 2023 Jan 30, 2024	BUY	$222.59 - $267.94 $84,806 - $102,085	381 Added 48.05%	1,174 $303,000
Q3 2023 Oct 23, 2023	SELL	$253.3 - $285.89 $15,704 - $17,725	-62 Reduced 7.25%	793 $203,000
Q2 2023 Jul 24, 2023	SELL	$275.25 - $318.06 $11,560 - $13,358	-42 Reduced 4.68%	855 $243,000
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $46,180 - $52,621	-180 Reduced 16.71%	897 $249,000
Q4 2022 Feb 10, 2023	BUY	$252.44 - $306.72 $76,994 - $93,549	305 Added 39.51%	1,077 $298,000
Q3 2022 Nov 09, 2022	BUY	$194.69 - $268.46 $150,300 - $207,251	772 New	772 $206,000
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $165,673 - $208,739	-855 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$223.92 - $287.77 $77,700 - $99,856	-347 Reduced 28.87%	855 $205,000
Q3 2021 Nov 09, 2021	SELL	$282.99 - $369.05 $19,526 - $25,464	-69 Reduced 5.43%	1,202 $340,000
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $18,389 - $29,444	71 Added 5.92%	1,271 $440,000
Q1 2021 May 11, 2021	SELL	$242.95 - $284.63 $297,370 - $348,387	-1,224 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$236.26 - $355.63 $146,244 - $220,134	-619 Reduced 33.59%	1,224 $300,000
Q3 2020 Nov 10, 2020	BUY	$264.77 - $305.71 $280,126 - $323,441	1,058 Added 134.78%	1,843 $523,000
Q2 2020 Aug 05, 2020	SELL	$258.66 - $342.55 $202,530 - $268,216	-783 Reduced 49.94%	785 $210,000
Q1 2020 May 11, 2020	BUY	$268.85 - $341.04 $421,556 - $534,750	1,568 New	1,568 $496,000
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $316,396 - $494,881	-1,460 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $1,114 - $1,411	4 Added 0.27%	1,460 $440,000
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $144,993 - $189,612	494 Added 51.35%	1,456 $514,000
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $772 - $920	-3 Reduced 0.31%	962 $279,000
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $35,377 - $50,035	-136 Reduced 12.35%	965 $264,000
Q4 2017 Feb 13, 2018	SELL	$307.64 - $344.58 $102,751 - $115,089	-334 Reduced 23.28%	1,101 $351,000
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $403,450 - $473,105	1,435	1,435 $449,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Svb Wealth LLC with notifications on news.

Account